Global Gastrointestinal Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Gastrointestinal Therapeutics market size was valued at USD 35120 million in 2023 and is forecast to a readjusted size of USD 49660 million by 2030 with a CAGR of 5.1% during review period.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
The Global Info Research report includes an overview of the development of the Gastrointestinal Therapeutics industry chain, the market status of IBD (Oral, Parenteral), Irritable Bowel Syndrome (IBS) (Oral, Parenteral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Therapeutics.
Regionally, the report analyzes the Gastrointestinal Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Parenteral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Therapeutics market.
Regional Analysis: The report involves examining the Gastrointestinal Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal Therapeutics:
Company Analysis: Report covers individual Gastrointestinal Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IBD, Irritable Bowel Syndrome (IBS)).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Therapeutics. It assesses the current state, advancements, and potential future developments in Gastrointestinal Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Gastrointestinal Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Therapeutics, with revenue, gross margin and global market share of Gastrointestinal Therapeutics from 2019 to 2024.
Chapter 3, the Gastrointestinal Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Therapeutics.
Chapter 13, to describe Gastrointestinal Therapeutics research findings and conclusion.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
The Global Info Research report includes an overview of the development of the Gastrointestinal Therapeutics industry chain, the market status of IBD (Oral, Parenteral), Irritable Bowel Syndrome (IBS) (Oral, Parenteral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Therapeutics.
Regionally, the report analyzes the Gastrointestinal Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Parenteral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Therapeutics market.
Regional Analysis: The report involves examining the Gastrointestinal Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal Therapeutics:
Company Analysis: Report covers individual Gastrointestinal Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IBD, Irritable Bowel Syndrome (IBS)).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Therapeutics. It assesses the current state, advancements, and potential future developments in Gastrointestinal Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oral
- Parenteral
- IBD
- Irritable Bowel Syndrome (IBS)
- AbbVie
- Allergan
- Johnson & Johnson
- Takeda
- Novartis
- Pfizer
- Merck
- F. Hoffmann-La Roche
- Eli Lilly
- AstraZeneca
- Procter & Gamble
- Tillotts Pharma
- Takeda
- GlaxoSmithKline
- Amgen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Gastrointestinal Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Therapeutics, with revenue, gross margin and global market share of Gastrointestinal Therapeutics from 2019 to 2024.
Chapter 3, the Gastrointestinal Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Therapeutics.
Chapter 13, to describe Gastrointestinal Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastrointestinal Therapeutics by Type
1.3.1 Overview: Global Gastrointestinal Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gastrointestinal Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Parenteral
1.4 Global Gastrointestinal Therapeutics Market by Application
1.4.1 Overview: Global Gastrointestinal Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 IBD
1.4.3 Irritable Bowel Syndrome (IBS)
1.5 Global Gastrointestinal Therapeutics Market Size & Forecast
1.6 Global Gastrointestinal Therapeutics Market Size and Forecast by Region
1.6.1 Global Gastrointestinal Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gastrointestinal Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Gastrointestinal Therapeutics Product and Solutions
2.1.4 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Gastrointestinal Therapeutics Product and Solutions
2.2.4 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions
2.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Gastrointestinal Therapeutics Product and Solutions
2.4.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Takeda Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Gastrointestinal Therapeutics Product and Solutions
2.5.4 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Gastrointestinal Therapeutics Product and Solutions
2.6.4 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Gastrointestinal Therapeutics Product and Solutions
2.7.4 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions
2.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Gastrointestinal Therapeutics Product and Solutions
2.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Gastrointestinal Therapeutics Product and Solutions
2.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Procter & Gamble
2.11.1 Procter & Gamble Details
2.11.2 Procter & Gamble Major Business
2.11.3 Procter & Gamble Gastrointestinal Therapeutics Product and Solutions
2.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Procter & Gamble Recent Developments and Future Plans
2.12 Tillotts Pharma
2.12.1 Tillotts Pharma Details
2.12.2 Tillotts Pharma Major Business
2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions
2.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Tillotts Pharma Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Gastrointestinal Therapeutics Product and Solutions
2.13.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions
2.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GlaxoSmithKline Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Gastrointestinal Therapeutics Product and Solutions
2.15.4 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Amgen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gastrointestinal Therapeutics by Company Revenue
3.2.2 Top 3 Gastrointestinal Therapeutics Players Market Share in 2023
3.2.3 Top 6 Gastrointestinal Therapeutics Players Market Share in 2023
3.3 Gastrointestinal Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Gastrointestinal Therapeutics Market: Region Footprint
3.3.2 Gastrointestinal Therapeutics Market: Company Product Type Footprint
3.3.3 Gastrointestinal Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastrointestinal Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Gastrointestinal Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Gastrointestinal Therapeutics Market Size by Country
6.3.1 North America Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Gastrointestinal Therapeutics Market Size by Country
7.3.1 Europe Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Gastrointestinal Therapeutics Market Size by Country
9.3.1 South America Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Gastrointestinal Therapeutics Market Drivers
11.2 Gastrointestinal Therapeutics Market Restraints
11.3 Gastrointestinal Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastrointestinal Therapeutics Industry Chain
12.2 Gastrointestinal Therapeutics Upstream Analysis
12.3 Gastrointestinal Therapeutics Midstream Analysis
12.4 Gastrointestinal Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Gastrointestinal Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastrointestinal Therapeutics by Type
1.3.1 Overview: Global Gastrointestinal Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gastrointestinal Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Parenteral
1.4 Global Gastrointestinal Therapeutics Market by Application
1.4.1 Overview: Global Gastrointestinal Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 IBD
1.4.3 Irritable Bowel Syndrome (IBS)
1.5 Global Gastrointestinal Therapeutics Market Size & Forecast
1.6 Global Gastrointestinal Therapeutics Market Size and Forecast by Region
1.6.1 Global Gastrointestinal Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gastrointestinal Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gastrointestinal Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Gastrointestinal Therapeutics Product and Solutions
2.1.4 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Gastrointestinal Therapeutics Product and Solutions
2.2.4 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions
2.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Gastrointestinal Therapeutics Product and Solutions
2.4.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Takeda Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Gastrointestinal Therapeutics Product and Solutions
2.5.4 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Gastrointestinal Therapeutics Product and Solutions
2.6.4 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Gastrointestinal Therapeutics Product and Solutions
2.7.4 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions
2.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Gastrointestinal Therapeutics Product and Solutions
2.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Gastrointestinal Therapeutics Product and Solutions
2.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Procter & Gamble
2.11.1 Procter & Gamble Details
2.11.2 Procter & Gamble Major Business
2.11.3 Procter & Gamble Gastrointestinal Therapeutics Product and Solutions
2.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Procter & Gamble Recent Developments and Future Plans
2.12 Tillotts Pharma
2.12.1 Tillotts Pharma Details
2.12.2 Tillotts Pharma Major Business
2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions
2.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Tillotts Pharma Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Gastrointestinal Therapeutics Product and Solutions
2.13.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions
2.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 GlaxoSmithKline Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Gastrointestinal Therapeutics Product and Solutions
2.15.4 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Amgen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gastrointestinal Therapeutics by Company Revenue
3.2.2 Top 3 Gastrointestinal Therapeutics Players Market Share in 2023
3.2.3 Top 6 Gastrointestinal Therapeutics Players Market Share in 2023
3.3 Gastrointestinal Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Gastrointestinal Therapeutics Market: Region Footprint
3.3.2 Gastrointestinal Therapeutics Market: Company Product Type Footprint
3.3.3 Gastrointestinal Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastrointestinal Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Gastrointestinal Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Gastrointestinal Therapeutics Market Size by Country
6.3.1 North America Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Gastrointestinal Therapeutics Market Size by Country
7.3.1 Europe Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Gastrointestinal Therapeutics Market Size by Country
9.3.1 South America Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Gastrointestinal Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Gastrointestinal Therapeutics Market Drivers
11.2 Gastrointestinal Therapeutics Market Restraints
11.3 Gastrointestinal Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastrointestinal Therapeutics Industry Chain
12.2 Gastrointestinal Therapeutics Upstream Analysis
12.3 Gastrointestinal Therapeutics Midstream Analysis
12.4 Gastrointestinal Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Gastrointestinal Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Gastrointestinal Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Gastrointestinal Therapeutics Product and Solutions
Table 8. AbbVie Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Gastrointestinal Therapeutics Product and Solutions
Table 13. Allergan Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions
Table 18. Johnson & Johnson Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson & Johnson Recent Developments and Future Plans
Table 20. Takeda Company Information, Head Office, and Major Competitors
Table 21. Takeda Major Business
Table 22. Takeda Gastrointestinal Therapeutics Product and Solutions
Table 23. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Takeda Recent Developments and Future Plans
Table 25. Novartis Company Information, Head Office, and Major Competitors
Table 26. Novartis Major Business
Table 27. Novartis Gastrointestinal Therapeutics Product and Solutions
Table 28. Novartis Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novartis Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Gastrointestinal Therapeutics Product and Solutions
Table 33. Pfizer Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Gastrointestinal Therapeutics Product and Solutions
Table 38. Merck Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Merck Recent Developments and Future Plans
Table 40. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 41. F. Hoffmann-La Roche Major Business
Table 42. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions
Table 43. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Gastrointestinal Therapeutics Product and Solutions
Table 48. Eli Lilly Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. AstraZeneca Company Information, Head Office, and Major Competitors
Table 51. AstraZeneca Major Business
Table 52. AstraZeneca Gastrointestinal Therapeutics Product and Solutions
Table 53. AstraZeneca Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. AstraZeneca Recent Developments and Future Plans
Table 55. Procter & Gamble Company Information, Head Office, and Major Competitors
Table 56. Procter & Gamble Major Business
Table 57. Procter & Gamble Gastrointestinal Therapeutics Product and Solutions
Table 58. Procter & Gamble Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Procter & Gamble Recent Developments and Future Plans
Table 60. Tillotts Pharma Company Information, Head Office, and Major Competitors
Table 61. Tillotts Pharma Major Business
Table 62. Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions
Table 63. Tillotts Pharma Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Tillotts Pharma Recent Developments and Future Plans
Table 65. Takeda Company Information, Head Office, and Major Competitors
Table 66. Takeda Major Business
Table 67. Takeda Gastrointestinal Therapeutics Product and Solutions
Table 68. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Takeda Recent Developments and Future Plans
Table 70. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 71. GlaxoSmithKline Major Business
Table 72. GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions
Table 73. GlaxoSmithKline Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Gastrointestinal Therapeutics Product and Solutions
Table 78. Amgen Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Global Gastrointestinal Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 81. Global Gastrointestinal Therapeutics Revenue Share by Players (2019-2024)
Table 82. Breakdown of Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Gastrointestinal Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Gastrointestinal Therapeutics Players
Table 85. Gastrointestinal Therapeutics Market: Company Product Type Footprint
Table 86. Gastrointestinal Therapeutics Market: Company Product Application Footprint
Table 87. Gastrointestinal Therapeutics New Market Entrants and Barriers to Market Entry
Table 88. Gastrointestinal Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Gastrointestinal Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Gastrointestinal Therapeutics Consumption Value Share by Type (2019-2024)
Table 91. Global Gastrointestinal Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 92. Global Gastrointestinal Therapeutics Consumption Value by Application (2019-2024)
Table 93. Global Gastrointestinal Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 94. North America Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Gastrointestinal Therapeutics Raw Material
Table 125. Key Suppliers of Gastrointestinal Therapeutics Raw Materials
Table 1. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Gastrointestinal Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Gastrointestinal Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Gastrointestinal Therapeutics Product and Solutions
Table 8. AbbVie Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Gastrointestinal Therapeutics Product and Solutions
Table 13. Allergan Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions
Table 18. Johnson & Johnson Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson & Johnson Recent Developments and Future Plans
Table 20. Takeda Company Information, Head Office, and Major Competitors
Table 21. Takeda Major Business
Table 22. Takeda Gastrointestinal Therapeutics Product and Solutions
Table 23. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Takeda Recent Developments and Future Plans
Table 25. Novartis Company Information, Head Office, and Major Competitors
Table 26. Novartis Major Business
Table 27. Novartis Gastrointestinal Therapeutics Product and Solutions
Table 28. Novartis Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novartis Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Gastrointestinal Therapeutics Product and Solutions
Table 33. Pfizer Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Gastrointestinal Therapeutics Product and Solutions
Table 38. Merck Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Merck Recent Developments and Future Plans
Table 40. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 41. F. Hoffmann-La Roche Major Business
Table 42. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions
Table 43. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Gastrointestinal Therapeutics Product and Solutions
Table 48. Eli Lilly Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. AstraZeneca Company Information, Head Office, and Major Competitors
Table 51. AstraZeneca Major Business
Table 52. AstraZeneca Gastrointestinal Therapeutics Product and Solutions
Table 53. AstraZeneca Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. AstraZeneca Recent Developments and Future Plans
Table 55. Procter & Gamble Company Information, Head Office, and Major Competitors
Table 56. Procter & Gamble Major Business
Table 57. Procter & Gamble Gastrointestinal Therapeutics Product and Solutions
Table 58. Procter & Gamble Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Procter & Gamble Recent Developments and Future Plans
Table 60. Tillotts Pharma Company Information, Head Office, and Major Competitors
Table 61. Tillotts Pharma Major Business
Table 62. Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions
Table 63. Tillotts Pharma Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Tillotts Pharma Recent Developments and Future Plans
Table 65. Takeda Company Information, Head Office, and Major Competitors
Table 66. Takeda Major Business
Table 67. Takeda Gastrointestinal Therapeutics Product and Solutions
Table 68. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Takeda Recent Developments and Future Plans
Table 70. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 71. GlaxoSmithKline Major Business
Table 72. GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions
Table 73. GlaxoSmithKline Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Gastrointestinal Therapeutics Product and Solutions
Table 78. Amgen Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Global Gastrointestinal Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 81. Global Gastrointestinal Therapeutics Revenue Share by Players (2019-2024)
Table 82. Breakdown of Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Gastrointestinal Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Gastrointestinal Therapeutics Players
Table 85. Gastrointestinal Therapeutics Market: Company Product Type Footprint
Table 86. Gastrointestinal Therapeutics Market: Company Product Application Footprint
Table 87. Gastrointestinal Therapeutics New Market Entrants and Barriers to Market Entry
Table 88. Gastrointestinal Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Gastrointestinal Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Gastrointestinal Therapeutics Consumption Value Share by Type (2019-2024)
Table 91. Global Gastrointestinal Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 92. Global Gastrointestinal Therapeutics Consumption Value by Application (2019-2024)
Table 93. Global Gastrointestinal Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 94. North America Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Gastrointestinal Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Gastrointestinal Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Gastrointestinal Therapeutics Raw Material
Table 125. Key Suppliers of Gastrointestinal Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Gastrointestinal Therapeutics Picture
Figure 2. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Parenteral
Figure 6. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Gastrointestinal Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. IBD Picture
Figure 9. Irritable Bowel Syndrome (IBS) Picture
Figure 10. Global Gastrointestinal Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Gastrointestinal Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Gastrointestinal Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Gastrointestinal Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Gastrointestinal Therapeutics Consumption Value Market Share by Region in 2023
Figure 15. North America Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Gastrointestinal Therapeutics Revenue Share by Players in 2023
Figure 21. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Gastrointestinal Therapeutics Market Share in 2023
Figure 23. Global Top 6 Players Gastrointestinal Therapeutics Market Share in 2023
Figure 24. Global Gastrointestinal Therapeutics Consumption Value Share by Type (2019-2024)
Figure 25. Global Gastrointestinal Therapeutics Market Share Forecast by Type (2025-2030)
Figure 26. Global Gastrointestinal Therapeutics Consumption Value Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Therapeutics Market Share Forecast by Application (2025-2030)
Figure 28. North America Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. France Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 45. China Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. India Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Gastrointestinal Therapeutics Market Drivers
Figure 63. Gastrointestinal Therapeutics Market Restraints
Figure 64. Gastrointestinal Therapeutics Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics in 2023
Figure 67. Manufacturing Process Analysis of Gastrointestinal Therapeutics
Figure 68. Gastrointestinal Therapeutics Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Gastrointestinal Therapeutics Picture
Figure 2. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Parenteral
Figure 6. Global Gastrointestinal Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Gastrointestinal Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. IBD Picture
Figure 9. Irritable Bowel Syndrome (IBS) Picture
Figure 10. Global Gastrointestinal Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Gastrointestinal Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Gastrointestinal Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Gastrointestinal Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Gastrointestinal Therapeutics Consumption Value Market Share by Region in 2023
Figure 15. North America Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Gastrointestinal Therapeutics Revenue Share by Players in 2023
Figure 21. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Gastrointestinal Therapeutics Market Share in 2023
Figure 23. Global Top 6 Players Gastrointestinal Therapeutics Market Share in 2023
Figure 24. Global Gastrointestinal Therapeutics Consumption Value Share by Type (2019-2024)
Figure 25. Global Gastrointestinal Therapeutics Market Share Forecast by Type (2025-2030)
Figure 26. Global Gastrointestinal Therapeutics Consumption Value Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Therapeutics Market Share Forecast by Application (2025-2030)
Figure 28. North America Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. France Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Gastrointestinal Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 45. China Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. India Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Gastrointestinal Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Gastrointestinal Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Gastrointestinal Therapeutics Market Drivers
Figure 63. Gastrointestinal Therapeutics Market Restraints
Figure 64. Gastrointestinal Therapeutics Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics in 2023
Figure 67. Manufacturing Process Analysis of Gastrointestinal Therapeutics
Figure 68. Gastrointestinal Therapeutics Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
